John E. Davis - 02 Jan 2024 Form 4 Insider Report for ARTIVION, INC. (AORT)

Signature
/s/ John E. Davis
Issuer symbol
AORT
Transactions as of
02 Jan 2024
Net transactions value
-$244,116
Form type
4
Filing time
04 Jan 2024, 16:22:34 UTC
Previous filing
30 Jan 2024
Next filing
22 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $221,061 +13,562 +11% $16.30 142,295 02 Jan 2024 Direct F1
transaction AORT Common Stock Sale $244,116 -13,562 -9.5% $18.00 128,733 02 Jan 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Option (Right to Buy) Options Exercise $221,061 -13,562 -100% $16.30 0 02 Jan 2024 Common Stock 13,562 $16.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023.
F2 Reflects the price the shares were sold.
F3 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018.